$4.86
0.22[4.74%]
At close: Apr 26
$4.86
0[0.00%]
After Hours: 7:49PM EDT
Terns Pharma: Insider buying and selling updated today.
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
---|---|---|---|---|---|---|---|---|---|---|
Apr 03, 2024 | Vivo Opportunity LLCVivo Opportunity Fund Holdings LPVivo Capital VIII LLCVivo Capital Fund VIII LPVivo Capital Surplus Fund VIII LP | 10% OWNER | -420.663K | $6.65 | -$2.80M | SELL | -61.03% | 268.573K | Apr 01 - Apr 03 | View |
Dec 04, 2023 | Seokho Bryan Yoon | COO AND GENERAL COUNSEL | 743 | $3.78 | $2.81K | BUY | 4.21% | 18.399K | Nov 30 | View |
Dec 04, 2023 | Mark J Vignola | CHIEF FINANCIAL OFFICER | 743 | $3.78 | $2.81K | BUY | 4.21% | 18.399K | Nov 30 | View |
Jun 02, 2023 | Mark J Vignola | CHIEF FINANCIAL OFFICER | 9.997K | $1.41 | $14.10K | BUY | 130.53% | 17.656K | May 31 | View |
Jun 02, 2023 | Seokho Bryan Yoon | COO AND GENERAL COUNSEL | 9.997K | $1.41 | $14.10K | BUY | 130.53% | 17.656K | May 31 | View |
Jun 02, 2023 | Senthil Sundaram | CHIEF EXECUTIVE OFFICER | 2.111K | $1.41 | $2.98K | BUY | 27.56% | 9.77K | May 31 | View |
Feb 03, 2023 | Seokho Bryan Yoon | COO AND GENERAL COUNSEL | 3 | $1.41 | $4.23 | BUY | 0.04% | 7.659K | Nov 30 | View |
Feb 03, 2023 | Mark J Vignola | CHIEF FINANCIAL OFFICER | 3 | $1.41 | $4.23 | BUY | 0.04% | 7.659K | Nov 30 | View |
Feb 03, 2023 | Senthil Sundaram | CHIEF EXECUTIVE OFFICER | 3 | $1.41 | $4.23 | BUY | 0.04% | 7.659K | Nov 30 | View |
Dec 28, 2022 | ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLCOrbiMed Asia GP III LPOrbiMed Advisors III LtdOrbiMed Genesis GP LLC | DIRECTOR | 137.931K | $7.25 | $1000.00K | BUY | 2.50% | 5.645254M | Dec 23 | View |
Dec 28, 2022 | Carl L Gordon | DIRECTOR | 137.931K | $7.25 | $1000.00K | BUY | 2.50% | 5.645254M | Dec 23 | View |
Dec 23, 2022 | Vivo Opportunity LLCVivo Opportunity Fund Holdings LPVivo Capital VIII LLCVivo Capital Fund VIII LPVivo Capital Surplus Fund VIII LP | 10% OWNER | 758.62K | $7.25 | $5.50M | BUY | 19.64% | 4.621435M | Dec 23 | View |
Dec 23, 2022 | Hongbo Lu | 758.62K | $7.25 | $5.50M | BUY | 21.18% | 4.340212M | Dec 23 | View | |
Nov 28, 2022 | LAV Biosciences Fund V LPHopewell Resources Holdings LtdLAV Aqua LtdOriental Spring Venture Ltd | 10% OWNER | -1.5M | $5.50 | -$8.25M | SELL | -45.23% | 1.81646M | Nov 23 | View |
Sep 08, 2022 | Vivo Opportunity LLCVivo Opportunity Fund Holdings LPVivo Capital VIII LLCVivo Capital Fund VIII LPVivo Capital Surplus Fund VIII LP | 10% OWNER | 600K | $3.60 | $2.16M | BUY | 18.39% | 3.862815M | Sep 07 | View |
Sep 08, 2022 | Hongbo Lu | 600K | $3.60 | $2.16M | BUY | 20.12% | 3.581592M | Sep 07 | View | |
Aug 18, 2022 | ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLCOrbiMed Asia GP III LPOrbiMed Advisors III LtdOrbiMed Genesis GP LLC | DIRECTOR | 3.69M | $2.42 | $8.93M | BUY | ∞ | 762.4K | Aug 16 | View |
Aug 18, 2022 | Carl L Gordon | DIRECTOR | 3.69M | $2.42 | $8.93M | BUY | ∞ | 762.4K | Aug 16 | View |
Aug 16, 2022 | Vivo Opportunity LLCVivo Opportunity Fund Holdings LPVivo Capital VIII LLCVivo Capital Fund VIII LPVivo Capital Surplus Fund VIII LP | 10% OWNER | 2.624239M | $2.66 | $6.98M | BUY | 410.95% | 3.262815M | Aug 12 - Aug 16 | View |
Browse insider trades on all stocks.